Vera Therapeutics, Inc. (VERA) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 2.14B USD. 52-week range 23.05 to 56.05 USD. Data as of 2026-10-09.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other ...